Jie Wang

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

23h-index3.0kcitations83works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(58), Lung Cancer Research Studies(23), Cancer Genomics and Diagnostics(20), Colorectal Cancer Treatments and Studies(14), Lung Cancer Diagnosis and Treatment(9)

Publications83 total

Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
The Lancet Respiratory Medicine·2025· 1 cited
Safety and efficacy of YK-029A in previously treated EGFR T790M-Mutant NSCLC: A multi-center phase I trial
Lung Cancer·2025
RANKL/PD-1 dual blockade demonstrates survival benefit for patients with advanced lung adenocarcinoma harboring KRAS mutations
Cell Reports Medicine·2025· 2 citedOpen Access
Characterization of a novel CmUFO mutation affecting floral development in melon
Horticultural Plant Journal·2025Open Access
Abstract P5-07-19: A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in Human Epidermal Growth Factor Receptor 2 positive (HER2+) early breast cancer (EBC) in China: NER-Tree study—An interim analysis on safety
Clinical Cancer Research·2025
EZH2 alters aggressive variant prostate cancer subtype evolution, but is not required for neuroendocrine prostate cancer
2025Open Access
CX3CR1 Functions as a Biomarker Associated with Pathological Tumor Staging in the Diagnosis and Prognosis of Prostate Cancer.
PubMed·2025
New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke prevention in East Asian populations: a systematic review and meta-analysis
Frontiers in Pharmacology·2025· 1 citedOpen Access
Detection and indications of circulating tumor cells in hepatocellular carcinoma
Analytical Methods·2025· 1 citedOpen Access
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial
Signal Transduction and Targeted Therapy·2024· 10 citedOpen Access
Prognostic prediction and treatment options for gastric signet ring cell carcinoma: a SEER database analysis
Frontiers in Oncology·2024· 5 citedOpen Access
Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors
European Journal of Medicinal Chemistry·2024· 6 cited
Therapeutic activity of a new KRAS<sup>G12C</sup> inhibitor JMKX001899 in brain metastases: Preclinical models of KRAS<sup>G12C</sup>-mutant non-small cell lung cancer.
Journal of Clinical Oncology·2024
ARTEMIS-001: Data from a phase 1a/b study of HS-20093 in patients with relapsed small cell lung cancer (SCLC).
Journal of Clinical Oncology·2024· 20 cited
Abstract CT055: Efficacy of YK-029A, a novel EGFR TKI, in advanced NSCLC patients with acquired T790M mutation
Cancer Research·2024
Effects of Azvudine on the Low-Risk Patients Infected with COVID-19 Omicron Variants: A Retrospective Case-Control Study
International Journal of Pharmacology·2024
Data from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
2023Open Access
Data from Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling
2023Open Access
Figure S2 from Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis
2023Open Access
Data from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Hua Bai(30), Tongtong An(28), Zhijie Wang(26), Jianchun Duan(25), Minglei Zhuo(24), Jun Zhao(23), Meina Wu(20), Yuyan Wang(18), Shuhang Wang(15), Lu Yang(10), Jia Zhong(8), Xin Wang(6), Jianchun Duan(6), Jun Zhao(5), Xiaodan Yang(3), X. Sunney Xie(3), Ke‐Neng Chen(3), Yanhua Tian(3), Qingzhi Guo(3), Xue Yang(3)